drugset / Trial / NCT01051479

A Pilot C11-Choline PET-CT Imaging Study in Patients With Locally Advanced Esophageal Cancer

NCT01051479

Phase 1 Completed 22 enrolled Wake Forest University Health Sciences
NaSingle-groupOpen-labelDiagnostic

Summary

The purpose of this study is to evaluate the investigators ability to obtain reliable and meaningful 11C-Choline PET-CT images of esophageal cancer.

Timeline

Start
2010-03
Primary completion
2013-08
Completion
2013-08

Drugs

EvaluationDrugModalityDoseRoute
Subject C11-Choline Diagnostic / imaging agent 555 mbq Intravenous

Indications